Stephen Williams, MD
Hematology & Oncology · Roseburg, ORNPI 1437370947
Payments from drug & device makers
Across 78 payments — averaging $66.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Onmark, Inc.$4K
- Amgen$165
- Zimmer Biomet$104
- Mirati Therapeutics, Inc.$101
- Novartis$93
- Pfizer$89
- plus $876 from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Onmark, Inc. | 11 | $3,744 |
| Amgen | 7 | $165 |
| Zimmer Biomet | 1 | $104 |
| Mirati Therapeutics, Inc. | 4 | $101 |
| Novartis | 5 | $93 |
| Pfizer | 5 | $89 |
| Gilead(2 entities) | 5 | $79 |
| Merck | 2 | $68 |
| AVEO Pharmaceuticals, Inc. | 3 | $66 |
| E.r. Squibb & Sons, L.L.C. | 3 | $58 |
| Eisai Inc. | 3 | $56 |
| GSK | 3 | $54 |
| Puma Biotechnology, Inc. | 3 | $54 |
| Genentech USA, Inc. | 3 | $51 |
| Johnson & Johnson | 2 | $49 |
| Sanofi | 3 | $44 |
| Array Biopharma Inc | 2 | $37 |
| Stemline Therapeutics Inc. | 1 | $25 |
| Exelixis Inc. | 1 | $24 |
| Myovant Sciences Inc. | 1 | $23 |
| AstraZeneca | 1 | $22 |
| Bristol Myers Squibb | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| EMD Serono, Inc. | 1 | $20 |
| Bayer | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| Tersera Therapeutics LLC | 1 | $18 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $17 |
| Spectrum Pharmaceuticals Inc. | 1 | $16 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
How this compares
$5,171 in reported general payments places this provider in the 50th percentile of 112 hematology & oncology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Roseburg
- Edward OttenheimerRoseburg$5K
- Joshua WeeseRoseburg$5K
- Michael HeinrichPortland$25M
- Jay AndersenPortland$8.3M
- Elie TraerPortland$6.5M
- Ian SchnadigTualatin$6.4M
- Jacqueline VukyPortland$5.4M
- Sandeep MashruPortland$4.6M
- Abdul Hai MansoorPortland$3.5M
- Aimee KohnPortland$3.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.